End-payors request consolidation, co-lead counsel in Solodyn litigation
MLex Summary: End-payor plaintiffs have filed a motion to consolidate their class action claims against drugmakers for allegedly conspiring to keep a generic form of Solodyn off the market. The plaintiffs have also requested that...To view the full article, register now.
Already a subscriber? Click here to view full article